Biotin-PEG4-NHS ester
貨號 | 數量 | 價格 | 交貨時間 | 購買此產品 |
---|---|---|---|---|
2893-100mg | 100 mg | $145 | 現貨 | |
2893-1g | 1 g | $590 | 現貨 |
Biotin-PEG4-NHS ester is an activated ester for simple and efficient biotin labeling of antibodies, proteins, and other primary amine-containing biomolecules. The NHS ester group reacts efficiently with amino groups by the nucleophilic attack, forming an amide bond and releasing N-Hydroxysuccinimide. Biotin-labeled compounds can then be linked to avidin or streptavidin for further purification or detection. The biotin group is relatively small and doesn’t affect the biological activity of biotinylated proteins.
This reagent features a long PEG4-linker that separates the biotin residue from the target molecule, ensuring efficient binding to avidin or streptavidin. The linker also increases the compound’s water solubility, thereby facilitating bioconjugation. Antibodies labeled with Biotin-PEG4-NHS ester exhibit less aggregation when stored in solution than those labeled with reagents with only hydrocarbon spacers.
顧客還購買了這個產品
AF 594 NHS酯 (AF 594 NHS ester)
AF 594 染料的紅色螢光 NHS-酯,用於標記蛋白質、肽、抗體和任何含有 -NH2 基團的分子。純5-異構體AF 647 NHS 酯 (AF 647 NHS ester)
明亮的水溶性琥珀醯亞胺酯AF 647染料,用於蛋白質和抗體標記。DMSO (dimethyl sulfoxide), labeling grade
Pure dimethyl sulfoxide (DMSO) solvent with quality optimized for bioconjugation reactions.General properties
Appearance: | white to off-beige powder |
Molecular weight: | 588.68 |
CAS number: | 459426-22-3 |
Molecular formula: | C25H40N4O10S |
Solubility: | water, DMSO, DMF, DCM |
Quality control: | NMR 1H and HPLC-MS (95+%) |
Storage conditions: | 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Desiccate. |
MSDS: | 下載 |
產品規格 |
產品引用
- Zhang, L.; Yang, C.; Li, Y.; Niu, S.; Liang, X.; Zhang, Z.; Luo, Q.; Luo, H. Dynamic Changes in the Levels of Amyloid-β 42 Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease. Frontiers in Molecular Neuroscience, 2021, 14, 723317. doi: 10.3389/fnmol.2021.723317